Skip to main content

Table 2 Anti-Spike nanobody affinity and neutralization potency

From: A potent synthetic nanobody with broad-spectrum activity neutralizes SARS-CoV-2 virus and the Omicron variant BA.1 through a unique binding mode

Antigen

B7

A11/D3

D8

D9

F12

G6

C5

C5G2

mNb6

RBD

S1/Spike

Spike

Spike

Spike

Spike

Spike

Spike

Spike

Spike

binding

KD(M)

  

3.05E-08

2.61E-07

1.46E-07

2.48E-07

   

Kon(1/Ms)

  

7.71E + 04

1.87E + 05

2.51E + 05

1.40E + 05

   

Kdis(1/s)

  

2.53E-03

4.87E-02

3.66E-02

3.46E-02

   

S1

binding

KD(M)

 

5.58E-10

       

Kon(1/Ms)

 

8.83E + 05

       

Kdis(1/s)

 

4.93E-04

       

RBD

binding

KD(M)

2.66E-07

     

1.80E-08

1.62E-09

3.48E-09

Kon(1/Ms)

2.59E + 05

     

1.44E + 04

1.76E + 04

1.63 + 04

Kdis(1/s)

6.87E-02

     

2.59E-04

2.84E-05

5.66E-05

Pseudo-

virus

IC50(M)

WT

 

N.E.

    

N.E.

1.59E-09

1.37E-08

Alpha

 

N.E.

    

N.E.

9.5E-10

2.69E-08

Beta

 

N.E.

    

8.16E-08

5.6E-10

N.E.

Gamma

 

N.E.

    

N.E.

1.06E-09

N.E.

Delta

 

N.E.

    

N.E.

N.E.

2.05E-08

Omicron

 

N.E.

    

2.1E-09

3.0E-10

N.E.

  1. NE.   no efficacy